Michaela Rutledge, PA
Physician Assistant · Dallas, TXNPI 1609437573
Payments from drug & device makers
Across 53 payments — averaging $86.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$1K
- Incyte Corporation$1K
- Johnson & Johnson$453
- Sanofi-aventis U.S. LLC$435
- Adaptive Biotechnologies Corporation$186
- Syndax Pharmaceuticals, Inc.$145
- plus $913 from 14 others
What the payments were for
- Consulting fees$1,79039%
- Travel & lodging$3047%
- Food & beverage$2,22649%
- Education$2586%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $1,270 |
| Incyte Corporation | 6 | $1,176 |
| Johnson & Johnson(2 entities) | 13 | $453 |
| Sanofi-aventis U.S. LLC | 4 | $435 |
| Adaptive Biotechnologies Corporation | 6 | $186 |
| Syndax Pharmaceuticals, Inc. | 1 | $145 |
| AstraZeneca | 1 | $124 |
| Astellas Pharma US Inc | 3 | $121 |
| Sobi, Inc | 1 | $119 |
| GSK | 1 | $111 |
| E.r. Squibb & Sons, L.L.C. | 2 | $108 |
| Legend Biotech USA Inc. | 1 | $95 |
| Janssen Scientific Affairs, LLC | 1 | $65 |
| Bard Peripheral Vascular, Inc. | 2 | $51 |
| AbbVie | 1 | $26 |
| Merck | 1 | $22 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| Genmab U.S., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,578 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Voriconazole | 37 | $6,914 |
| ValacyclovirValacyclovir Hcl | 25 | $2,034 |
| Ursodiol | 21 | $1,396 |
| Fluconazole | 24 | $1,111 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,102 |
| Acyclovir | 133 | $1,048 |
| Tacrolimus | 20 | $952 |
| Budesonide DrBudesonide | 14 | $810 |
| Famciclovir | 16 | $711 |
| Levetiracetam | 11 | $643 |
| Megestrol Acetate | 14 | $515 |
| Potassium Chloride | 47 | $471 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $387 |
| Gabapentin | 42 | $382 |
| Ondansetron OdtOndansetron | 23 | $380 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Dallas
- Cynthia TrickettDallas$1.3M
- Michael WhiteDallas$276K
- Sofia NeicherilDallas$62K
- Shawn SommerladDallas$53K
- Katherine TurnerDallas$43K
- Tori BurnsDallas$39K
- Suzanne RaczDallas$32K
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.